CD4 and allergic asthma: Although there are reports in the available literature on the effect of different JAK inhibitors on the development of animal models of lung inflammation [16,17,18,19,20], their effect on the accompanying CD4+ T cell immune response in the inductive and effector compartments associated with pathogenesis of allergic asthma has not been investigated thus far.